Noble Financial Downgrades Pharmasset (VRUS) to Sell
Tweet
Share
E-mailGet Alerts VRUS Hot Sheet
Price: $0.00 --0%
Rating Summary:
3 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 26 | New: 4
Rating Summary:
3 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 26 | New: 4
Join SI Premium – FREE
Noble Financial downgraded Pharmasset (NASDAQ: VRUS) from Buy to Sell, price target raised from $95 to $135.
For an analyst ratings summary and ratings history on Pharmasset click here. For more ratings news on Pharmasset click here.
Shares of Pharmasset closed at $134.14 yesterday.
For an analyst ratings summary and ratings history on Pharmasset click here. For more ratings news on Pharmasset click here.
Shares of Pharmasset closed at $134.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Insulet Corporation (PODD) to Perform
- Citi cuts Burlington Stores rating to Neutral with $380 target
- Desjardins Downgrades TELUS Corp. (T:CN) (TU) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Noble FinancialSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
